Alcon, the eye care business of Novartis, has announced plans to locate its future global headquarters in Geneva once its proposed spinoff from Novartis International is complete. The Swiss group decided to cut ties with Alcon in July, to focus on its portfolio of pharmaceutical products (see Eyewear Intelligence, Vol. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.